Aspergillus terreus is a filamentous fungus commonly found in soil and decaying plant material. It can cause various human infections, particularly in immunocompromised individuals.
The epidemiology of A. terreus infections needs to be better understood due to the rarity of these infections and the difficulty in accurately identifying the species. However, studies have suggested that A. terreus infections are more common in tropical and subtropical regions, particularly in India and parts of Africa.
Risk factors for A. terreus infections include immunosuppression, particularly in patients with hematological malignancies or solid organ transplants, and prolonged use of broad-spectrum antibiotics and corticosteroids.
A. terreus is known to produce a variety of mycotoxins, including patulin, citrinin, and ochratoxin A, which can contaminate food and feed and pose a risk to human and animal health. Therefore, there is also a need to understand the epidemiology of A. terreus about mycotoxin production and contamination.
Its structure can be described as follows:
Hyphae: Aspergillus terreus has hyphae, which are long, branching, thread-like structures that make up the body of the fungus. The hyphae are divided into compartments by septa or cross-walls.
Conidiophores: Conidiophores are specialized structures that produce asexual spores called conidia. In A. terreus, the conidiophores are branched and have a swollen base called a vesicle.
Conidia: Conidia are asexual spores produced by the conidiophores. They are small, single-celled structures that can be dispersed by air. In A. terreus, the conidia are smooth, spherical, and brownish-yellow in color.
Mycelium: Mycelium is the vegetative part of the fungus, composed of a network of hyphae. In A. terreus, the mycelium grows on the surface of the substrate and can form a dense mat.
Sclerotia: Sclerotia are compact masses of fungal hyphae capable of surviving adverse environmental conditions. In A. terreus, sclerotia are formed when the fungus is grown on a solid substrate.
Classification:
Kingdom: Fungi
Division: Ascomycota
Class: Eurotiomycetes
Order: Eurotiales
Family: Trichocomaceae
Genus: Aspergillus
Species: A. terreus
Aspergillus terreus can produce a variety of antigens that the host immune system can recognize. However, the antigenic types of Aspergillus terreus must be better defined and may vary depending on the specific strain or isolate.
One of the most studied antigens of Aspergillus terreus is galactomannan, a cell wall component that can be detected in patient samples using a specific enzyme-linked immunosorbent assay (ELISA). The presence of galactomannan is often used as a diagnostic marker for invasive aspergillosis caused by Aspergillus terreus.
Other antigens reported in Aspergillus terreus include cell wall proteins, heat-shock proteins, and secreted enzymes such as proteases and lipases. More study is necessary to thoroughly characterize the antigenic varieties of Aspergillus terreus and its relevance in clinical situations.
The pathogenesis of A. terreus involves several steps:
Adhesion: A. terreus spores adhere to host tissues, which is facilitated by various adhesins present on the surface of the spores.
Germination: The spores germinate into hyphae, which penetrate the host tissues and form a network of branching filaments.
Growth: The hyphae continue to grow and invade deeper tissues, releasing enzymes and toxins that damage host cells and tissues.
Immune evasion: A. terreus has various mechanisms to evade host immune responses, such as producing proteases that degrade immunoglobulins and complement proteins.
Disease manifestation: The clinical manifestations of A. terreus infections depend on the site of infection and the host’s immune status. In immunocompromised individuals, A. terreus can cause invasive pulmonary aspergillosis, which is associated with high mortality rates. It can also cause invasive aspergillosis in other organs, such as the brain, liver, and spleen.
the host defenses against Aspergillus terreus:
Innate immune response: The innate immune response is the first defense against Aspergillus terreus infection. It involves activating various cells and molecules, including macrophages, neutrophils, complement proteins, and natural killer cells, which work together to identify and eliminate the fungus.
Adaptive immune response: The adaptive immune response is a more specific and targeted response that involves activating B cells and T cells, which produce antibodies and cytokines to neutralize the fungus and stimulate an immune response.
Epithelial barriers: Epithelial barriers, such as the skin and mucous membranes, are physical barriers to prevent Aspergillus terreus from entering the body.
Antifungal medications: Antifungal medications like azoles and echinocandins can treat Aspergillus terreus infections by inhibiting fungal growth and replication.
Immunomodulatory therapies: Immunomodulatory therapies, such as granulocyte-colony stimulating factor (G-CSF) and interferon-gamma (IFN-gamma), can stimulate the immune response and enhance host defenses against Aspergillus terreus.
The clinical manifestations of Aspergillus terreus infection include:
Invasive pulmonary aspergillosis (IPA): This is a severe fungal infection that affects the lungs and can spread to other body parts. Symptoms may include fever, cough, chest pain, shortness of breath, and fatigue.
Sinusitis: Aspergillus terreus can cause inflammation of the sinuses, which can lead to symptoms such as facial pain, headache, nasal congestion, and post-nasal drip.
Skin infections: Aspergillus terreus can infect the skin, causing redness, itching, and the formation of pimples or lesions.
Eye infections: Aspergillus terreus can infect the eyes, causing pain, redness, swelling, and blurred vision.
Systemic infections: In rare cases, Aspergillus terreus can cause systemic infections, affecting multiple organs and leading to sepsis.
Diagnosing Aspergillus terreus infection involves several methods, including clinical evaluation, radiological imaging, and laboratory tests.
Clinical Evaluation: Diagnosing Aspergillus terreus infection involves assessing the patient’s symptoms and medical history. Common symptoms of Aspergillus terreus infection include fever, cough, chest pain, and shortness of breath. Patients with compromised immune systems are more susceptible to this infection.
Radiological Imaging: Imaging studies such as chest X-rays or computed tomography (CT) scans can help detect the presence of Aspergillus terreus infection. Imaging may reveal lung cavities, nodules, or other lung abnormalities.
Laboratory Tests: Laboratory tests used to diagnose Aspergillus terreus infection include:
Sputum culture: A sample of the patient’s sputum is collected and sent to the laboratory for culture. The culture will show if Aspergillus terreus is present in the sample.
Blood tests: Blood tests can help detect the presence of Aspergillus terreus antibodies or antigens.
Biopsy: A biopsy may be needed to confirm the diagnosis in rare cases. A little tissue sample from the lungs or another damaged location is taken to be examined under a microscope.
The following measures can be taken to control the growth of this fungus.
Good sanitation practices: Regular cleaning and disinfection of surfaces and equipment in food processing and storage facilities can help prevent contamination and the growth of Aspergillus terreus.
Temperature control: Aspergillus terreus grows well in warm and humid conditions. Therefore, maintaining proper temperature and humidity levels in storage areas and during transportation can help control its growth.
Moisture control: Aspergillus terreus requires moisture to grow. Controlling the moisture content of food products and using proper packaging materials can help prevent their growth.
Chemical control: Fungicides can control Aspergillus terreus growth in certain situations. However, using chemicals should be done according to recommended guidelines and in compliance with local regulations.
Genetic control: The development of resistant strains of crops and genetic modification of food products to prevent fungal growth is an emerging field of research.
Aspergillus terreus is a filamentous fungus commonly found in soil and decaying plant material. It can cause various human infections, particularly in immunocompromised individuals.
The epidemiology of A. terreus infections needs to be better understood due to the rarity of these infections and the difficulty in accurately identifying the species. However, studies have suggested that A. terreus infections are more common in tropical and subtropical regions, particularly in India and parts of Africa.
Risk factors for A. terreus infections include immunosuppression, particularly in patients with hematological malignancies or solid organ transplants, and prolonged use of broad-spectrum antibiotics and corticosteroids.
A. terreus is known to produce a variety of mycotoxins, including patulin, citrinin, and ochratoxin A, which can contaminate food and feed and pose a risk to human and animal health. Therefore, there is also a need to understand the epidemiology of A. terreus about mycotoxin production and contamination.
Its structure can be described as follows:
Hyphae: Aspergillus terreus has hyphae, which are long, branching, thread-like structures that make up the body of the fungus. The hyphae are divided into compartments by septa or cross-walls.
Conidiophores: Conidiophores are specialized structures that produce asexual spores called conidia. In A. terreus, the conidiophores are branched and have a swollen base called a vesicle.
Conidia: Conidia are asexual spores produced by the conidiophores. They are small, single-celled structures that can be dispersed by air. In A. terreus, the conidia are smooth, spherical, and brownish-yellow in color.
Mycelium: Mycelium is the vegetative part of the fungus, composed of a network of hyphae. In A. terreus, the mycelium grows on the surface of the substrate and can form a dense mat.
Sclerotia: Sclerotia are compact masses of fungal hyphae capable of surviving adverse environmental conditions. In A. terreus, sclerotia are formed when the fungus is grown on a solid substrate.
Classification:
Kingdom: Fungi
Division: Ascomycota
Class: Eurotiomycetes
Order: Eurotiales
Family: Trichocomaceae
Genus: Aspergillus
Species: A. terreus
Aspergillus terreus can produce a variety of antigens that the host immune system can recognize. However, the antigenic types of Aspergillus terreus must be better defined and may vary depending on the specific strain or isolate.
One of the most studied antigens of Aspergillus terreus is galactomannan, a cell wall component that can be detected in patient samples using a specific enzyme-linked immunosorbent assay (ELISA). The presence of galactomannan is often used as a diagnostic marker for invasive aspergillosis caused by Aspergillus terreus.
Other antigens reported in Aspergillus terreus include cell wall proteins, heat-shock proteins, and secreted enzymes such as proteases and lipases. More study is necessary to thoroughly characterize the antigenic varieties of Aspergillus terreus and its relevance in clinical situations.
The pathogenesis of A. terreus involves several steps:
Adhesion: A. terreus spores adhere to host tissues, which is facilitated by various adhesins present on the surface of the spores.
Germination: The spores germinate into hyphae, which penetrate the host tissues and form a network of branching filaments.
Growth: The hyphae continue to grow and invade deeper tissues, releasing enzymes and toxins that damage host cells and tissues.
Immune evasion: A. terreus has various mechanisms to evade host immune responses, such as producing proteases that degrade immunoglobulins and complement proteins.
Disease manifestation: The clinical manifestations of A. terreus infections depend on the site of infection and the host’s immune status. In immunocompromised individuals, A. terreus can cause invasive pulmonary aspergillosis, which is associated with high mortality rates. It can also cause invasive aspergillosis in other organs, such as the brain, liver, and spleen.
the host defenses against Aspergillus terreus:
Innate immune response: The innate immune response is the first defense against Aspergillus terreus infection. It involves activating various cells and molecules, including macrophages, neutrophils, complement proteins, and natural killer cells, which work together to identify and eliminate the fungus.
Adaptive immune response: The adaptive immune response is a more specific and targeted response that involves activating B cells and T cells, which produce antibodies and cytokines to neutralize the fungus and stimulate an immune response.
Epithelial barriers: Epithelial barriers, such as the skin and mucous membranes, are physical barriers to prevent Aspergillus terreus from entering the body.
Antifungal medications: Antifungal medications like azoles and echinocandins can treat Aspergillus terreus infections by inhibiting fungal growth and replication.
Immunomodulatory therapies: Immunomodulatory therapies, such as granulocyte-colony stimulating factor (G-CSF) and interferon-gamma (IFN-gamma), can stimulate the immune response and enhance host defenses against Aspergillus terreus.
The clinical manifestations of Aspergillus terreus infection include:
Invasive pulmonary aspergillosis (IPA): This is a severe fungal infection that affects the lungs and can spread to other body parts. Symptoms may include fever, cough, chest pain, shortness of breath, and fatigue.
Sinusitis: Aspergillus terreus can cause inflammation of the sinuses, which can lead to symptoms such as facial pain, headache, nasal congestion, and post-nasal drip.
Skin infections: Aspergillus terreus can infect the skin, causing redness, itching, and the formation of pimples or lesions.
Eye infections: Aspergillus terreus can infect the eyes, causing pain, redness, swelling, and blurred vision.
Systemic infections: In rare cases, Aspergillus terreus can cause systemic infections, affecting multiple organs and leading to sepsis.
Diagnosing Aspergillus terreus infection involves several methods, including clinical evaluation, radiological imaging, and laboratory tests.
Clinical Evaluation: Diagnosing Aspergillus terreus infection involves assessing the patient’s symptoms and medical history. Common symptoms of Aspergillus terreus infection include fever, cough, chest pain, and shortness of breath. Patients with compromised immune systems are more susceptible to this infection.
Radiological Imaging: Imaging studies such as chest X-rays or computed tomography (CT) scans can help detect the presence of Aspergillus terreus infection. Imaging may reveal lung cavities, nodules, or other lung abnormalities.
Laboratory Tests: Laboratory tests used to diagnose Aspergillus terreus infection include:
Sputum culture: A sample of the patient’s sputum is collected and sent to the laboratory for culture. The culture will show if Aspergillus terreus is present in the sample.
Blood tests: Blood tests can help detect the presence of Aspergillus terreus antibodies or antigens.
Biopsy: A biopsy may be needed to confirm the diagnosis in rare cases. A little tissue sample from the lungs or another damaged location is taken to be examined under a microscope.
The following measures can be taken to control the growth of this fungus.
Good sanitation practices: Regular cleaning and disinfection of surfaces and equipment in food processing and storage facilities can help prevent contamination and the growth of Aspergillus terreus.
Temperature control: Aspergillus terreus grows well in warm and humid conditions. Therefore, maintaining proper temperature and humidity levels in storage areas and during transportation can help control its growth.
Moisture control: Aspergillus terreus requires moisture to grow. Controlling the moisture content of food products and using proper packaging materials can help prevent their growth.
Chemical control: Fungicides can control Aspergillus terreus growth in certain situations. However, using chemicals should be done according to recommended guidelines and in compliance with local regulations.
Genetic control: The development of resistant strains of crops and genetic modification of food products to prevent fungal growth is an emerging field of research.
Aspergillus terreus is a filamentous fungus commonly found in soil and decaying plant material. It can cause various human infections, particularly in immunocompromised individuals.
The epidemiology of A. terreus infections needs to be better understood due to the rarity of these infections and the difficulty in accurately identifying the species. However, studies have suggested that A. terreus infections are more common in tropical and subtropical regions, particularly in India and parts of Africa.
Risk factors for A. terreus infections include immunosuppression, particularly in patients with hematological malignancies or solid organ transplants, and prolonged use of broad-spectrum antibiotics and corticosteroids.
A. terreus is known to produce a variety of mycotoxins, including patulin, citrinin, and ochratoxin A, which can contaminate food and feed and pose a risk to human and animal health. Therefore, there is also a need to understand the epidemiology of A. terreus about mycotoxin production and contamination.
Structure and Classification
Its structure can be described as follows:
Hyphae: Aspergillus terreus has hyphae, which are long, branching, thread-like structures that make up the body of the fungus. The hyphae are divided into compartments by septa or cross-walls.
Conidiophores: Conidiophores are specialized structures that produce asexual spores called conidia. In A. terreus, the conidiophores are branched and have a swollen base called a vesicle.
Conidia: Conidia are asexual spores produced by the conidiophores. They are small, single-celled structures that can be dispersed by air. In A. terreus, the conidia are smooth, spherical, and brownish-yellow in color.
Mycelium: Mycelium is the vegetative part of the fungus, composed of a network of hyphae. In A. terreus, the mycelium grows on the surface of the substrate and can form a dense mat.
Sclerotia: Sclerotia are compact masses of fungal hyphae capable of surviving adverse environmental conditions. In A. terreus, sclerotia are formed when the fungus is grown on a solid substrate.
Classification:
Kingdom: Fungi
Division: Ascomycota
Class: Eurotiomycetes
Order: Eurotiales
Family: Trichocomaceae
Genus: Aspergillus
Species: A. terreus
Antigenic Types
Aspergillus terreus can produce a variety of antigens that the host immune system can recognize. However, the antigenic types of Aspergillus terreus must be better defined and may vary depending on the specific strain or isolate.
One of the most studied antigens of Aspergillus terreus is galactomannan, a cell wall component that can be detected in patient samples using a specific enzyme-linked immunosorbent assay (ELISA). The presence of galactomannan is often used as a diagnostic marker for invasive aspergillosis caused by Aspergillus terreus.
Other antigens reported in Aspergillus terreus include cell wall proteins, heat-shock proteins, and secreted enzymes such as proteases and lipases. More study is necessary to thoroughly characterize the antigenic varieties of Aspergillus terreus and its relevance in clinical situations.
Pathogenesis
The pathogenesis of A. terreus involves several steps:
Adhesion: A. terreus spores adhere to host tissues, which is facilitated by various adhesins present on the surface of the spores.
Germination: The spores germinate into hyphae, which penetrate the host tissues and form a network of branching filaments.
Growth: The hyphae continue to grow and invade deeper tissues, releasing enzymes and toxins that damage host cells and tissues.
Immune evasion: A. terreus has various mechanisms to evade host immune responses, such as producing proteases that degrade immunoglobulins and complement proteins.
Disease manifestation: The clinical manifestations of A. terreus infections depend on the site of infection and the host’s immune status. In immunocompromised individuals, A. terreus can cause invasive pulmonary aspergillosis, which is associated with high mortality rates. It can also cause invasive aspergillosis in other organs, such as the brain, liver, and spleen.
Host Defenses
the host defenses against Aspergillus terreus:
Innate immune response: The innate immune response is the first defense against Aspergillus terreus infection. It involves activating various cells and molecules, including macrophages, neutrophils, complement proteins, and natural killer cells, which work together to identify and eliminate the fungus.
Adaptive immune response: The adaptive immune response is a more specific and targeted response that involves activating B cells and T cells, which produce antibodies and cytokines to neutralize the fungus and stimulate an immune response.
Epithelial barriers: Epithelial barriers, such as the skin and mucous membranes, are physical barriers to prevent Aspergillus terreus from entering the body.
Antifungal medications: Antifungal medications like azoles and echinocandins can treat Aspergillus terreus infections by inhibiting fungal growth and replication.
Immunomodulatory therapies: Immunomodulatory therapies, such as granulocyte-colony stimulating factor (G-CSF) and interferon-gamma (IFN-gamma), can stimulate the immune response and enhance host defenses against Aspergillus terreus.
Clinical manifestations
The clinical manifestations of Aspergillus terreus infection include:
Invasive pulmonary aspergillosis (IPA): This is a severe fungal infection that affects the lungs and can spread to other body parts. Symptoms may include fever, cough, chest pain, shortness of breath, and fatigue.
Sinusitis: Aspergillus terreus can cause inflammation of the sinuses, which can lead to symptoms such as facial pain, headache, nasal congestion, and post-nasal drip.
Skin infections: Aspergillus terreus can infect the skin, causing redness, itching, and the formation of pimples or lesions.
Eye infections: Aspergillus terreus can infect the eyes, causing pain, redness, swelling, and blurred vision.
Systemic infections: In rare cases, Aspergillus terreus can cause systemic infections, affecting multiple organs and leading to sepsis.
Diagnosis
Diagnosing Aspergillus terreus infection involves several methods, including clinical evaluation, radiological imaging, and laboratory tests.
Clinical Evaluation: Diagnosing Aspergillus terreus infection involves assessing the patient’s symptoms and medical history. Common symptoms of Aspergillus terreus infection include fever, cough, chest pain, and shortness of breath. Patients with compromised immune systems are more susceptible to this infection.
Radiological Imaging: Imaging studies such as chest X-rays or computed tomography (CT) scans can help detect the presence of Aspergillus terreus infection. Imaging may reveal lung cavities, nodules, or other lung abnormalities.
Laboratory Tests: Laboratory tests used to diagnose Aspergillus terreus infection include:
Sputum culture: A sample of the patient’s sputum is collected and sent to the laboratory for culture. The culture will show if Aspergillus terreus is present in the sample.
Blood tests: Blood tests can help detect the presence of Aspergillus terreus antibodies or antigens.
Biopsy: A biopsy may be needed to confirm the diagnosis in rare cases. A little tissue sample from the lungs or another damaged location is taken to be examined under a microscope.
Control
The following measures can be taken to control the growth of this fungus.
Good sanitation practices: Regular cleaning and disinfection of surfaces and equipment in food processing and storage facilities can help prevent contamination and the growth of Aspergillus terreus.
Temperature control: Aspergillus terreus grows well in warm and humid conditions. Therefore, maintaining proper temperature and humidity levels in storage areas and during transportation can help control its growth.
Moisture control: Aspergillus terreus requires moisture to grow. Controlling the moisture content of food products and using proper packaging materials can help prevent their growth.
Chemical control: Fungicides can control Aspergillus terreus growth in certain situations. However, using chemicals should be done according to recommended guidelines and in compliance with local regulations.
Genetic control: The development of resistant strains of crops and genetic modification of food products to prevent fungal growth is an emerging field of research.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
